No abstract available
MeSH terms
-
Breast Neoplasms / epidemiology
-
Estrogen Antagonists / adverse effects
-
Estrogen Antagonists / therapeutic use*
-
Estrogens / agonists*
-
Female
-
Female Urogenital Diseases / chemically induced*
-
Female Urogenital Diseases / epidemiology
-
Humans
-
Indoles / adverse effects
-
Indoles / therapeutic use
-
Osteoporosis, Postmenopausal / drug therapy
-
Postmenopause / drug effects*
-
Pyrrolidines / adverse effects
-
Pyrrolidines / therapeutic use*
-
Raloxifene Hydrochloride / adverse effects
-
Raloxifene Hydrochloride / therapeutic use
-
Receptors, Estrogen
-
Selective Estrogen Receptor Modulators / adverse effects
-
Selective Estrogen Receptor Modulators / therapeutic use*
-
Tamoxifen / adverse effects
-
Tamoxifen / therapeutic use
-
Tetrahydronaphthalenes / adverse effects
-
Tetrahydronaphthalenes / therapeutic use*
Substances
-
Estrogen Antagonists
-
Estrogens
-
Indoles
-
Pyrrolidines
-
Receptors, Estrogen
-
Selective Estrogen Receptor Modulators
-
Tetrahydronaphthalenes
-
Tamoxifen
-
Lasofoxifene
-
Raloxifene Hydrochloride
-
bazedoxifene